Altice USA Inc. (NYSE: ATUS): BofA Securities downgraded the stock to Underperform from Neutral and has a $38 price target. The consensus target is $42.02, and the shares ended trading Monday at $36.96.
Arena Pharmaceuticals Inc. (NASDAQ: ARNA): Goldman Sachs started coverage with a Buy rating and a $90 price target. That compares with a $98.07 consensus and Monday’s closing print of $60.89.
Banco Santander S.A. (NYSE: BSMX): JPMorgan’s upgrade to Overweight from Neutral comes with a $6.50 price target. The consensus target is up at $7.05, and Monday’s last trade came in at $5.81.
CASI Pharmaceuticals Inc. (NASDAQ: CASI): BTIG started coverage with a Buy rating and a $4 price target. The consensus is $4.27, but the stock closed Monday at $1.44.
Cerence Inc. (NASDAQ: CRNC): Evercore ISI raised the shares to Outperform from Inline and has a $125 price target. The posted consensus target is $121.55, and the stock was last seen on Monday at $83.33.
CrowdStrike Holdings Inc. (NASDAQ: CRWD): This cybersecurity play was named as the Zacks Bear of the Day. The firm points out that earnings estimates have been cut on this endpoint security leader. Shares last closed at $188.53 and have a consensus price target of $253.23.
Gap Inc. (NYSE: GPS): Credit Suisse raised the apparel retail giant to Neutral from Underperform and has a $23 price target. The consensus target is $29.89, and the stock closed above both levels Monday at $36.33.
II-VI Inc. (NASDAQ: IIVI): Barclays downgraded the shares to Equal Weight from Overweight and lowered the price target to $65. The consensus price objective is up at $92.22. The shares ended Monday’s trading at $63.57 apiece.
Lumentum Holdings Inc. (NASDAQ: LITE): Barclays resumed coverage with an Overweight rating and an $85 price target. The higher consensus price objective is $91.60. The last trade to hit the tape Monday came in at $72.18 per share, after rising over 3% on the day.
Marathon Petroleum Corp. (NYSE: MPC): Credit Suisse resumed coverage of the energy giant with an Outperform rating and a $74 price target. The consensus target is $66.62, and the shares closed Monday at $61.52 apiece.